Skip to content
Axcess News – Lifestyle
Author:
Regentis Biomaterials Ltd
Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement
June 17, 2026
Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate
June 8, 2026
Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon
April 16, 2026
Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%
March 17, 2026
Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update
March 5, 2026
Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair
March 5, 2026